Hormonal contraception and PMS. Inger Sundström Poromaa Department of Women s and Children s Health Uppsala University
|
|
- Rafe Wade
- 5 years ago
- Views:
Transcription
1 Hormonal contraception and PMS Inger Sundström Poromaa Department of Women s and Children s Health Uppsala University
2 Definitions Premenstrual syndrome (PMS) ICD 10: Two symptoms, at least one psychological, regularly recurring in the premenstrual week Prevalence 17-18% Premenstrual dysphoric disorder (PMDD) DSM-5: Five symptom, at least four psychological, regularly recurring in the premenstrual week Prevalence 3% Treatment studies primarily done in PMDD
3 Prevalence of premenstrual symptoms
4 Progesterone causes the symptoms Mood symptoms with hormonal contraception Mood symptoms during sequential HRT resemble PMS GnRH agonists alleviate symptoms Progesterone treatment ineffective
5 RCTs on antidepressants Stone AB, et al. Fluoxetine. Psychopharmacol Bull. 1990; Veeninga AT, et al. Fluoxetine. Psychopharmacology (Berl). 1990; Stone AB et al. Fluoxetine. J Clin Psychiatry Sundblad C et al. Clomipramine. Acta Psychiatr Scand Wood SH et al. Fluoxetine. Obstet Gynecol Sundblad C et al. Clomipramine. Neuropsychopharmacology Eriksson E et al. Paroxetine. Neuropsychopharmacology Steiner M et al. Fluoxetine. N Engl J Med Halbreich U and Smoller JW. Sertraline. J Clin Psychiatry Pearlstein TB et al. Fluoxetine,. J Clin Psychopharmacol Su TP et al. Fluoxetine. Neuropsychopharmacology Yonkers KA et al. Sertraline. JAMA Wikander I et al. Citalopram. J Clin Psychopharmacol Young SA et al. Sertraline. J Clin Psychiatry Freeman EW et al. Fluoxetine. J Clin Psychopharmacol Freeman EW et al. Fluoxetine. Arch Gen Psychiatry Jermain DM et al. Sertraline. Arch Fam Med Freeman EW et al. Venlafaxine. Obstet Gynecol Cohen LS et al. Fluoxetine. Obstet Gynecol Halbreich U et al. Sertraline. Obstet Gynecol Hunter MS et al. Fluoxetine. J Psychosom Obstet Gynaecol Miner C et al. Fluoxetine. Clin Ther Cohen LS et al. Paroxetine. Psychosom Med Freeman EW et al. Sertraline. Am J Psychiatry Freeman EW et al. Escitalopram. J Clin Psychiatry Steiner M et al. Paroxetine. Am J Obstet Gynecol Yonkers KA et al. Sertraline. J Affect Disord Kornstein SG et al. Sertraline. J Clin Psychiatry Yonkers KA et al. Sertraline. J Clin Psychopharmacol Landen M et al. Paroxetine. Neuropsychopharmacology Eriksson E et al. Escitalopram. J Clin Psychopharmacol Steiner M et al. Paroxetine. J Clin Psychiatry Wu KY et al. Paroxetine. Psychiatry Clin Neurosci Yonkers et al. Sertraline. JAMA Psychiatry. 2015
6 Antidepressant use in PMDS Higher response rate than in depression (60-90% responders) Response within 48 hours Cyclic treatment days before menses All serotonergic antidepressants work chose the one you know
7 How about hormonal contraception? Combined oral contraceptives Mirena? Esmya?
8 Yasmin for PMS/PMDD Drosperinone similar to spironolactone 82 women with PMDD Placebo-controlled RCT Significant improvement in appetite, acne and food cravings Freeman, 2002.
9 YAZ and PMDD 2 placebo-controlled studies 328 PMDD women, parallel Improved with YAZ (24/4) Yonkers et al, Obstet Gynecol PMDD women, cross-over Improved with YAZ (24/4) Pearlstein et al, Contraception 2005
10 Cross-over study YAZ DRSP Sum Score Baseline End of Treatment Period 1 End of Washout Phase End of Treatment Period 2 Group 1 - Placebo) (YAZ Group 2 (Placebo - YAZ) Pearlstein T et al. Contraception 2005;
11 Parallel study - YAZ 0 depressed anxious mood swings angry less interest concentration lethargic appetite sleep out of control physical ** *** *** *** ** *** ** ** ** ** *** YAZ Placebo Kimberley A. et al, Obst & Gynecol 2005; Vol 106 :
12 BUT the PMDD women often complain they cannot tolerate combined hormonal contraception
13 Placebo-controlled RCT in healthy women Lundin C, Danielsson KG, Bixo M, Moby L, Bengtsdotter H, Jawad I, Marions L, Brynhildsen J, Malmborg A, Lindh I, Sundstrom Poromaa I. Psychoneuroendocrinology. 2017;76:
14 Mirena? Leminen A et al. Acta Obstet Gynecol Scand 2012;91(3):318-25
15 Mifepristone? Halbreich U. Psychiatry Nov;53(4):407-9.
16 Mifepristone? Two small published studies on single-dose mifepristone One unpublished study with positive results Some studies on high-dose mifepristone on psychotic depression
17 Esmya, ongoing trial in women with PMDD
18 Conclusion Low-dose 24/4 combined oral contraceptives can be used to treat PMDD Be ware of increased symptoms in the intermenstrual phase SSRI appear superior in the clinic but head-to-head comparisons are lacking
Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder
human psychopharmacology Hum Psychopharmacol Clin Exp 2003; 18: 191 195. Published online 23 December 2002 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/hup.470 Fluoxetine versus Vitex
More informationTreatment of Mood Disorders in Midlife Women
Treatment of Mood Disorders in Women KAY ROUSSOS-ROSS, MD UNIVERSITY OF FLORIDA DEPARTMENTS OF OBGYN AND PSYCHIATRY Disclosures I HAVE NO DISCLOSURES Objectives UNDERSTAND INCIDENCE OF MOOD DISORDERS IN
More informationPremenstrual dysphoric disorder (PMDD)
EXPANDING CHOICES IN TREATING PREMENSTRUAL DYSPHORIC DISORDER * Bruce Kessel, MD* ABSTRACT Over the past 2 decades, considerable progress has occurred in the understanding, diagnosis, and clinical management
More informationPlacebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual Dysphoric Disorder
(2007) 32, 153 161 & 2007 Nature Publishing Group All rights reserved 0893-133X/07 $30.00 www.neuropsychopharmacology.org Placebo-Controlled Trial Comparing Intermittent and Continuous Paroxetine in Premenstrual
More informationDaily Record of Severity of Problems (DRSP): reliability and validity
Arch Womens Ment Health (2006) 9: 41 49 DOI 10.1007/s00737-005-0103-y Original contribution Daily Record of Severity of Problems (DRSP): reliability and validity J. Endicott 1, J. Nee 1, and W. Harrison
More informationThe term premenstrual disorders
REPORTS New Treatment Approaches for Premenstrual Disorders Andrea J. Rapkin, MD Abstract Several approaches to alleviating the symptoms of premenstrual disorders are available to women and can be tailored
More informationApproximately 75% of women experience a premenstrual
Premenstrual dysphoric disorder: How to alleviate her suffering Accurate diagnosis, tailored treatments can greatly improve women s quality of life Laura Wakil, MD Third-Year Psychiatry Resident Samantha
More informationPremenstrual Syndrome Latest Definitions, Management Guidelines & Research
Nick Panay BSc FRCOG MFSRH Imperial College Healthcare NHS Trust & Chelsea and Westminster Hospital London Chair: National Association for Premenstrual Syndrome Premenstrual Syndrome Latest Definitions,
More informationMANAGEMENT OF PREMENSTRUAL DISORDERS
Review Article MANAGEMENT OF PREMENSTRUAL DISORDERS Anisha Nakulan Assistant Professor, Department of Psychiatry, Amala Institute of Medical Sciences, Thrissur. Correspondence: Department of Psychiatry,
More informationWomen s Mental Health
Learning Objectives Women s Mental Health Know what to do when a pt c/o PMS Gain knowledge about depression in women Be able to review risks/benefits of antidepressants during pregnancy Learn about post-partum
More informationMental Health for Women s Health
Mental Health for Women s Health Ellen Haller, M.D. WomenCare Mental Health Program Depression Center @ UCSF UCSF Department of Learning Objectives Know what to do when a pt c/o PMS Gain knowledge about
More informationSpecial Issues in Menopause and Major Depressive Disorder
September 11, 2013 By Barbara L. Parry, MD [1] A risk to benefit ratio of treatment must be established to determine the optimal treatment for perimenopausal depression. Untreated depression during the
More informationPremenstrual Syndrome Management Options
Management Options Nicholas Panay Consultant Gynaecologist, Queen Charlotte s & Chelsea Hospital and Chelsea & Westminster Hospital, Honorary Senior Lecturer Imperial College West London Menopause & PMS
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationIs Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A
Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A Faculty/Presenter Disclosures Faculty: Mike Allan Salary: College
More informationDiagnosis, pathophysiology and management of premenstrual syndrome
DOI: 10.1111/tog.12180 The Obstetrician & Gynaecologist http://onlinetog.org 2015;17:99 104 Review Diagnosis, pathophysiology and management of premenstrual syndrome Sally Walsh MBCHB, a, * Elgerta Ismaili
More informationTreatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol
REVIEW Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol Domenico De Berardis 1,2,3 Nicola Serroni 2 Rosa Maria Salerno 1 Filippo Maria
More informationDrug Surveillance 1.
22 * * 3 1 2 3. 4 Drug Surveillance 1. 6-9 2 3 DSM-IV Anxious depression 4 Drug Surveillance GPRD A. (TCA) (SSRI) (SNRI) 20-77 - SSRI 1999 SNRI 2000 5 56 80 SSRI 1 1999 2005 2 2005 92.4, 2010 1999 3 1
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationA Review of Treatment and Management Modalities for Premenstrual Dysphoric Disorder
A Review of Treatment and Management Modalities for Premenstrual Dysphoric Disorder KELLI KELDERHOUSE, MSN, RN, FNP-C JULIE SMITH TAYLOR, PhD, RN, WHNP-BC Approximately 5 percent to 8 percent of women
More informationAssessment and Management of Depression Over the Female Life Cycle
Assessment and Management of Depression Over the Female Life Cycle Stephen A. Young, MD Regional Medical Officer/Psychiatry US Department of State, American Embassy, Tokyo Office of Personnel Management
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:
Studies listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationMental Health and Women s Health
Disclosure information I have nothing to disclose. Mental Health and Women s Health Ellen Haller, M.D. Professor of Clinical UCSF Department of Learning Objectives Know what to do when a pt c/o PMS/PMDD
More informationEffects of Antidepressants on Quality of Life in Women with Premenstrual Dysphoric Disorder
Pharmacoeconomics 2005; 23 (5): 433-444 CURRENT OPINION 1170-7690/05/0005-0433/$34.95/0 2005 Adis Data Information BV. All rights reserved. Effects of Antidepressants on Quality of Life in Women with Premenstrual
More information1 de 13 22/03/ :17 p.m.
1 de 13 22/03/2014 05:17 p.m. Premenstrual syndrome Updated 2013 Aug 14 05:00:00 PM: SSRIs may be effective for reducing PMS symptoms (Cochrane Database Syst Rev 2013 Jun 7) view update Show more updates
More informationExploring New Treatment Options. case study on PMDD and the current recommendations for treatment. A Case Study on PMDD
M A N A G I N G PMS& PMDD Exploring New Treatment Options Most women of reproductive age some 85 percent experience recurrent mood and somatic symptoms with their menstrual cycles (ACOG, 2000). The symptoms
More informationStudy No: Title: Rationale: . Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationPremenstrual Syndrome
page 1 Premenstrual Syndrome Q: What is premenstrual syndrome (PMS)? A: Premenstrual syndrome (PMS) is a group of symptoms linked to the menstrual cycle. PMS symptoms occur in the week or two weeks before
More informationOral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen
American Journal of Obstetrics and Gynecology (2006) 195, 1311 9 www.ajog.org Oral contraceptives and premenstrual symptoms: Comparison of a 21/7 and extended regimen Andrea L. Coffee, PharmD,* Thomas
More informationPattern of premenstrual symptoms among pre-clinical medical students at the University of Nigeria
ORIGINAL ARTICLE Pattern of premenstrual symptoms among pre-clinical medical students at the University of Nigeria Lawrence C IKEAKO 1 Hyginus U EZEGWUI 2 Michael I NWAFOR 2 Eric E NWAOGU- IKEOJO 2 1Department
More informationEndocrinology, Menstrual cycle, Menopause and. Prof Bev Lawton (Anna Fenton) Centre for Women s Health Research Victoria Unversity Wellington
Endocrinology, Menstrual cycle, Menopause and Management Prof Bev Lawton (Anna Fenton) Centre for Women s Health Research Victoria Unversity Wellington Female Menstrual Cycle Relevance to psychiatry? Missing
More informationThe biology of menstrually related. Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives REPORTS. Patricia J.
REPORTS Ovulation Suppression of Premenstrual Symptoms Using Oral Contraceptives Patricia J. Sulak, MD Abstract Managing premenstrual symptoms at the most fundamental level necessitates careful consideration
More informationVitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review
Arch Womens Ment Health https://doi.org/10.1007/s00737-017-0791-0 REVIEW ARTICLE Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review Raphael O. Cerqueira
More information23/05/18. Mood changes in postmenopausal women treated with progesterone
//8 Is Premenstrual syndrome (PMS) / Premenstrual dysphoric disorder (PMDD) due to paradoxical effects of progesterone metabolites and possible to treat? Torbjörn Bäckström MD., PhD., Professor Umeå Neurosteroid
More informationPMS / PMDD. Prof John Studd Imperial College London London PMS and Menopause Centre. www. studd.co.uk
PMS / PMDD Prof John Studd Imperial College London London PMS and Menopause Centre www. studd.co.uk PMS or PMDD????? 2 3 St Luke s hospital for the insane 1846 F > M x 2 most common in women of the servant
More informationAverage dose zoloft for ocd and anxiety
Average dose zoloft for ocd and anxiety Gogamz Menu DESCRIPTION. Selective serotonin reuptake inhibitor (SSRI). Approved for depression, OCD, panic disorder, PTSD, premenstrual-dysphoric disorder (PMDD),
More informationInformation for you. Managing premenstrual syndrome (PMS) What is PMS?
Managing premenstrual syndrome (PMS) Information for you Published in August 2009 What is PMS? Premenstrual syndrome or PMS is the name given to a collection of physical and emotional symptoms that can
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objective: Primary Outcome/Efficacy Variable:
Studies listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationPremenstrual Dysphoric Disorder
CE/CME Premenstrual Dysphoric Disorder Diagnosis and Management in Primary Care Jovanka Rajic, MSN, RN, NP, FNP-C, PHN, Stefanie A. Varela, RN, PHN, MSN-EDU, FNP, WHNP-BC, PhD The severe psychiatric and
More informationNumerous symptoms are commonly attributed to
Symptoms in the Menopausal Transition Hormone and Behavioral Correlates Ellen W. Freeman, PhD, Mary D. Sammel, ScD, Hui Lin, MS, Clarisa R. Gracia, MD, and Shiv Kapoor, PhD OBJECTIVE: To estimate the association
More informationApproach to Premenstrual Dysphoria for the Mental Health Practitioner
Approach to Premenstrual Dysphoria for the Mental Health Practitioner Simone N. Vigod, MD, FRCPC a, Benicio N. Frey, MD, PhD b,c, Claudio N. Soares, MD, PhD, FRCPC b,c,d,e, Meir Steiner, MD, PhD, FRCPC
More informationManagement of a HIV-infected patient with a psychiatric disorder
Management of a HIV-infected patient with a psychiatric disorder Maria Ferrara, Modena, Italia Guida Da Ponte, Lisboa, Portugal Jordi Blanch, Barcelona Main complaint Mr M is a 30-year-old HIV+ man In
More informationPREMENSTRUAL SYNDROME: PREVALENCE IN STUDENTS OF THE UNIVERSITY OF CALABAR, NIGERIA
African Journal of Biomedical Research, Vol. 7 (2004); 45-50 ISSN 1119 5096 Ibadan Biomedical Communications Group Full Length Research Article PREMENSTRUAL SYNDROME: PREVALENCE IN STUDENTS OF THE UNIVERSITY
More informationPremenstrual dysphoric disorder: current status of treatment
Original article Peer reviewed article SWISS MED WKLY 2002;132:574 578 www.smw.ch 574 Premenstrual dysphoric disorder: current status of treatment Francesco Bianchi-Demicheli, Frank Lüdicke, Hervé Lucas,
More informationInternational Journal of Basic and Applied Physiology
Effect Of Anemia On Premenstrual Syndrome In Adolescent Girls Mitesh Sinha*, Archana H Patel*, Shobha Naik**, J.M.Jadeja*** *Resident, **Add. Professor, ***Professor,Department of Physiology,B. J. Medical
More informationMar 6, The most effective medications are described in the next section. Selective serotonin reuptake inhibitors (SSRIs) SSRIs are a highly
Mar 6, 2017. The most effective medications are described in the next section. Selective serotonin reuptake inhibitors (SSRIs) SSRIs are a highly effective treatment for the symptoms of PMS and PMDD. The
More informationOutline. Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly. Definitions
Outline Understanding Placebo Response in Psychiatry: The Good, The Bad, and The Ugly Michael E. Thase, MD Professor of Psychiatry Perelman School of Medicine University of Pennsylvania and Philadelphia
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1998, by the Massachusetts Medical Society VOLUME 338 J ANUARY 22, 1998 NUMBER 4 DIFFERENTIAL BEHAVIORAL EFFECTS OF GONADAL STEROIDS IN WOMEN WITH AND IN
More informationWHI Estrogen--Progestin vs. Placebo (Women with intact uterus)
HORMONE REPLACEMENT THERAPY In the historical period it was commonly held that estrogen had two principal benefits to postmenopausal women: 1) To alleviate the constitutional symptoms related to the climacteric
More informationClinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant
The Clinical Significance of Anxiety Disorders and the DSM-5 Anxious Distress Specifier in Depressed Patients Clinical Significance of Anxiety in Depressed Patients Selecting an Antidepressant Rhode Island
More informationMental Illness Through Menopause
Mental Illness Through Menopause Susan Hatters Friedman, MD Associate Professor of Psychological Medicine University of Auckland Mental Illness: Depression Bipolar Schizophrenia PTSD & Anxiety Comorbidity
More informationDiagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD
Diagnosis & Management of Major Depression: A Review of What s Old and New Cerrone Cohen, MD Why You re Treating So Much Mental Health 59% of Psychiatrists Are Over the Age of 55 AAMC 2014 Physician specialty
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationInformation for you. Managing premenstrual syndrome (PMS) What is PMS?
Managing premenstrual syndrome (PMS) Information for you Published in August 2009 What is PMS? Premenstrual syndrome or PMS is the name given to a collection of physical and emotional symptoms that can
More informationManagement of Perimenopausal symptoms
Management of Perimenopausal symptoms Serge Rozenberg CHU St Pierre Université libre de Bruxelles Belgium serge_rozenberg@stpierre-bru.be serge.rozenberg@skynet.be Conflict of interest & Disclosure Conflicts
More informationGender-Specific Differences in Depression and Treatment Response
099-112_PBAut/sup_Kornstein 11/20/02 1:18 PM Page 99 Key Words: antidepressive agents, depression, depressive disorder, drug therapy, gender differences, menopause, mood disorders, perimenopause, pharmacotherapy
More informationObjectives. Sexual dysfunction (SD) SD in the general population. Assessment of sexual functioning ANTIDEPRESSANT-INDUCED SEXUAL DYSFUNCTION
Objectives To appreciate the relationship between major depressive disorder, its treatment and sexual dysfunction To review the assessment of sexual function An approach to the clinical management of antidepressant
More informationPremenstrual Syndrome
page 1 Premenstrual Syndrome Q: What is premenstrual syndrome (PMS)? A: Premenstrual (pree-men-struhl) syndrome (PMS) is a group of symptoms linked to the menstrual cycle. PMS symptoms occur 1 to 2 weeks
More informationAssessment and Treatment of Depression in Menopause
Disclosures Assessment and Treatment of Depression in Menopause Susan G. Kornstein, MD Professor of Psychiatry and Obstetrics-Gynecology Executive Director, Institute for Women s Health Virginia Commonwealth
More informationPharmacological treatment of anxiety disorders where is
Pharmacological treatment of anxiety disorders where is the room for improvement? David S Baldwin, Professor of Psychiatry BAP Masterclass, 15 th April 2011 dsb1@soton.ac.uk Declaration of interests (last
More informationPERIMENOPAUSAL. For personal use only. Copyright Dowden Health Media
For mass reproduction, content licensing and permissions contact Dowden Health Media. PERIMENOPAUSAL Copyright Dowden Health Media For personal use only depression Covering mood and vasomotor symptoms
More informationTherapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?
Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises? Prof. Dr. Christoph Hiemke Psychiatrische Klinik und Poliklinik Universität Mainz Psychopharmacotherapy Psychiatric Patient
More informationWHAT S NEW. Vilazodone (Viibryd ) Vilazodone - Dosing ANTIDEPRESSANT UPDATE: What s New? The Cardiac Debate The Efficacy Debate?Pharmacogenomics?
ANTIDEPRESSANT UPDATE: What s New? The Cardiac Debate The Efficacy Debate?Pharmacogenomics? Rex S. Lott, Pharm.D., BCPP Professor, ISU College of Pharmacy Mental Health Clinical Pharmacist, Boise VAMC
More informationPSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust
PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions
More informationSevere premenstrual syndrome (premenstrual dysphoric
Article Effects of Metergoline on Symptoms in Women With Premenstrual Dysphoric Disorder Catherine A. Roca, M.D. Peter J. Schmidt, M.D. Mark J. Smith, M.D., Ph.D. Merry A. Danaceau, R.N. Dennis L. Murphy,
More informationDocument Title Pharmacological Management of Generalised Anxiety Disorder
Document Title Pharmacological Management of Generalised Anxiety Disorder Document Description Document Type Policy Service Application Trust Wide Version 1.1 Policy Reference no. POL 201 Lead Author(s)
More informationSupplementary Online Content
Supplementary Online Content Blumenthal SR, Castro VM, Clements CC, et al. An electronic health records study of long-term weight gain following antidepressent use. JAMA Psychiatry. Published online June
More informationRelieving Premenstrual Syndrom Symptoms With Foot Reflexology as a Complementary Therapy Summary
SUMMARY www.inter-uni.net > Forschung Relieving Premenstrual Syndrom Symptoms With Foot Reflexology as a Complementary Therapy Summary Teja Vovk Supervisor: Elke Mesenholl-Strehler Introduction Premenstrual
More informationWomens Early Years. Nayan Patel PharmD
Womens Early Years. Nayan Patel PharmD Dr. Katharina Dalton (OBGYN) Treating PMS since 1953 with Dr. Greene (Endocrinologist) This is the 6 th edition published in 1999 Definition * PMS - is a group of
More informationPremenstrual Syndrome, Premenstrual Dysphoric Disorder, and Beyond: A Clinical Primer for Practitioners
CLINICAL GYNECOLOGIC SERIES: AN EXPERT S VIEW We have invited select authorities to present background information on challenging clinical problems and practical information on diagnosis and treatment
More informationDepression. University of Illinois at Chicago College of Nursing
Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationMother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants
Handout for the Neuroscience Education Institute (NEI) online activity: Mother May I? Managing Mental Illness During Pregnancy: Focus on Antidepressants Learning Objectives Evaluate the potential risks
More informationJMSCR Volume 03 Issue 04 Page April 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Prevalence of Pre-Menstrual Syndrome in Medical Student Population and Their Relief Measures - A Cross Sectional Study Authors Gantala
More informationAntidepressant does not relieve repetitive behaviors
NEWS Antidepressant does not relieve repetitive behaviors BY KELLY RAE CHI 16 JUNE 2009 1 / 5 Bitter pill: Negative results from clinical trials of two antidepressants, Celexa and Prozac, challenge the
More informationDegree of Premenstrual Mood Cyclicity is Predictive of Elevated Tonic Interleukin-6 Levels in Women with Menstrually-Related Mood Disorder
Degree of Premenstrual Mood Cyclicity is Predictive of Elevated Tonic Interleukin-6 Levels in Women with Menstrually-Related Mood Disorder Priyenka Niju Khatiwada A thesis submitted to the faculty at the
More informationHARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other BUPROPION HCL WELLBUTRIN, 01653 WELLBUTRIN SR, WELLBUTRIN XL BUPROPION HBR APLENZIN 17050 16996 26198 CITALOPRAM CELEXA 10321 GPID 16344 HYDROBROMIDE DESVENLAFAXINE
More informationDepression & Anxiety in Adolescents
Depression & Anxiety in Adolescents Objectives 1) Review diagnosis of anxiety and depression in adolescents 2) Provide overview of evidence-based treatment options 3) Increase provider comfort level with
More informationDepartment of Psychiatry & Behavioral Sciences. University of Texas Medical Branch
Depression in Childhood: Advances and Controversies in Treatment Karen Dineen Wagner, MD, PhD Marie B. Gale Centennial Professor & Vice Chair Department of Psychiatry & Behavioral Sciences Director, Division
More informationTreating treatment resistant depression
Treating treatment resistant depression These slides are the intellectual property of Ian Anderson and must not be reproduced Ian Anderson Neuroscience and Psychiatry Unit University of Manchester and
More informationPostpartum Mood Disorders
Postpartum Mood Disorders Marlene P. Freeman, M.D. Associate Professor of Psychiatry, Harvard Medical School Associate Director, Perinatal and Reproductive Psychiatry Medical Director, CTNI Massachusetts
More informationAntidepressant Selection in Primary Care
Antidepressant Selection in Primary Care R E B E C C A D. L E W I S, D O O O A S U M M E R C M E B R A N S O N, M O 1 5 A U G U S T 2 0 1 5 Objectives Understand the epidemiology of depression. Recognize
More informationSeptember 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by
September 26 28, 2013 Westin Tampa Harbour Island Co-sponsored by Best Practices in the Management of Bipolar Disorder Robert M. A. Hirschfeld, MD University of Texas Medical Branch Galveston, TX Peter
More informationAntidepressant Medication Strategies We ve Come a Long Way or Have We? Who Writes Prescriptions for Psychotropic Medications. Biological Psychiatry
Antidepressant Medication Strategies We ve Come a Long Way or Have We? Joe Wegmann, PD, LCSW The PharmaTherapist Joe@ThePharmaTherapist.com 504.587.9798 www.pharmatherapist.com Are you receiving our free
More informationStart Low, Go Slow but Treat to Target
Start Low, Go Slow but Treat to Target Pharmacotherapy for Depression, Anxiety and At-Risk Alcohol Use in Late Life September 29, 2014 Audio and Control Panel instruction On the phone? Raise your hand
More informationHormone therapy for menopausal vasomotor symptoms
Hormone therapy for menopausal vasomotor symptoms Given our available (better) options for treating hot flashes, can we reduce our use of medroxyprogesterone acetate? OBG Manag. 2014;26(7):10,13 15. Robert
More informationSevere premenstrual syndrome and bipolar disorder: a tragic confusion
Menopause International 2012; 18: 82 86. DOI: 10.1258/mi.2012.012018 Original article Severe premenstrual syndrome and bipolar disorder: a tragic confusion John Studd London PMS and Menopause Centre, 46
More informationAntidepressant tapering advice
Antidepressant tapering advice Professor Tony Kendrick et al, NIHR REDUCE Programme in the UK has kindly made this available to New Zealand prescribers as there is little empirical evidence on how to taper
More informationManaging premenstrual syndrome (PMS)
Information for you Published in March 2018 Managing premenstrual syndrome (PMS) About this information This information is for you if you have, or think you have, premenstrual syndrome (PMS) and want
More informationReviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression
CLINICAL AUDIT Reviewing the long-term use of selective serotonin reuptake inhibitors in patients with depression Valid to November 2022 bpac nz better medicin e Audit Focus This audit helps health professionals
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
Study No.: 29060/717 Title: A Double-Blind, Placebo-Controlled, 3-Arm, Fixed-Dose Study of CR Intermittent Dosing (12.5 mg and 25 mg) for Premenstrual Dysphoric Disorder Rationale: In most trials investigating
More informationPRIMARY CARE PSYCHIATRY VOL. 9, NO. 1, 2003, 15 20
PRIMARY CARE PSYCHIATRY VOL. 9, NO. 1, 2003, 15 20 10.1185/135525703125002342 2003 LIBRAPHARM LIMITED Use of St John s wort (Hypericum perforatum L) in members of a depression self-help organisation: a
More informationSuitable dose and duration of fluvoxamine administration to treat depression
PCN Psychiatric and Clinical Neurosciences 1323-13162003 Blackwell Science Pty Ltd 572April 2003 1098 Dose and duration of fluvoxamine S. Morishita and S. Arita 10.1046/j.1323-1316.2002.01098.x Original
More informationPremenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences
The Open Psychiatry Journal, 2009, 3, 47-57 47 Open Access Premenstrual Syndrome and Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences Faustino R. Pérez-López *,1, Peter Chedraui 2, Gonzalo
More informationPostpartum Depression. Deborah Kim, M.D. Assistant Professor Department of Psychiatry
Postpartum Depression Deborah Kim, M.D. Assistant Professor Department of Psychiatry drkim@upenn.edu Objectives Describe the difference between baby blues and postpartum depression (PPD) Describe the prevalence
More informationNon hormonal medical treatment of vasomotor symptoms
Non hormonal medical treatment of vasomotor symptoms Caroline Antoine Menopause Clinic Department of Gynaecology and Obstetrics CHU Saint-Pierre Belgian Menopause Society Symposium November 14, 2015 No
More informationPremenstrual Syndrome and Premenstrual Dysphoric Disorder
Premenstrual Syndrome and Premenstrual Dysphoric Disorder SABRINA HOFMEISTER, DO, and SETH BODDEN, MD, Medical College of Wisconsin, Milwaukee, Wisconsin Premenstrual disorders affect up to 12% of women.
More informationD I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.
Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor
More information